The Effect of Black Tea and Caffeine on Regional Cerebral Blood Flow Measured with Arterial Spin Labeling

Black tea consumption has been shown to improve peripheral vascular function. Its effect on brain vasculature is unknown, though tea contains small amounts of caffeine, a psychoactive substance known to influence cerebral blood flow (CBF). We investigated the effects on CBF due to the intake of tea components in 20 healthy men in a double-blinded, randomized, placebo-controlled study. On separate days, subjects received a single dose of 184 mg caffeine (equivalent to one strong espresso coffee), 2,820 mg black tea solids containing 184 mg caffeine (equivalent to 6 cups of tea), 2,820 mg decaffeinated black tea solids, or placebo. The CBF and cerebrovascular reactivity (CVR) to hypercapnia were measured with arterial spin labeled magnetic resonance imaging (MRI) before and 2 hours after administration. We found a significant global reduction with caffeine (20%) and tea (21%) in gray matter CBF, with no effect of decaffeinated tea, suggesting that only caffeine influences CBF acutely. Voxelwise analysis revealed the effect of caffeine to be regionally specific. None of the interventions had an effect on CVR. Additional research is required to conclude on the physiologic relevance of these findings and the chronic effects of caffeine and tea intake on CBF.

[1]  H. Roberts,et al.  Review sectionCaffeine consumption , 1996 .

[2]  O. Cameron,et al.  Caffeine and human cerebral blood flow: a positron emission tomography study. , 1990, Life sciences.

[3]  R. Traystman Regulation of Cerebral Blood Flow by Carbon Dioxide , 1997 .

[4]  W. O. Fenn,et al.  EFFECT OF CO2 ON RESPIRATION USING A NEW METHOD OF ADMINISTERING CO2. , 1963, Journal of applied physiology.

[5]  F. Ciruela,et al.  Adenosine‐glutamate receptor–receptor interactions in the central nervous system , 2001 .

[6]  Farzaneh A. Sorond,et al.  Cerebral blood flow response to flavanol-rich cocoa in healthy elderly humans , 2008, Neuropsychiatric disease and treatment.

[7]  R. Buxton,et al.  Quantitative imaging of perfusion using a single subtraction (QUIPSS and QUIPSS II) , 1998 .

[8]  H. Roberts,et al.  Caffeine consumption. , 1996, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[9]  A. Ngai,et al.  Adenosine receptors mediate glutamate-evoked arteriolar dilation in the rat cerebral cortex. , 2003, American journal of physiology. Heart and circulatory physiology.

[10]  Laura M Parkes,et al.  Improved accuracy of human cerebral blood perfusion measurements using arterial spin labeling: Accounting for capillary water permeability , 2002, Magnetic resonance in medicine.

[11]  N. Benowitz,et al.  Clinical pharmacology of caffeine. , 1990, Annual review of medicine.

[12]  R E Lenkinski,et al.  Magnetic resonance imaging of the brain: Blood partition coefficient for water: Application to spin‐tagging measurement of perfusion , 1996, Journal of magnetic resonance imaging : JMRI.

[13]  J. Hodgson,et al.  Effects of black tea on blood pressure: a randomized controlled trial. , 2012, Archives of internal medicine.

[14]  P. Smits,et al.  The cardiovascular effects of methylxanthines. , 2011, Handbook of experimental pharmacology.

[15]  S Thesen,et al.  Prospective acquisition correction for head motion with image‐based tracking for real‐time fMRI , 2000, Magnetic resonance in medicine.

[16]  D. Jenkinson,et al.  Caffeine reduces cerebral blood flow in patients recovering from an ischaemic stroke. , 2004, Age and ageing.

[17]  K. Fuxe,et al.  Adenosine/dopamine receptor‐receptor interactions in the central nervous system , 2001 .

[18]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[19]  Effects of physiological aging and cerebrovascular risk factors on the hemodynamic response to brain activation: a functional transcranial Doppler study , 2007 .

[20]  A Berthoz,et al.  A positron emission tomography study of oculomotor imagery. , 1994, Neuroreport.

[21]  E. Rimm,et al.  Relative impact of flavonoid composition, dose and structure on vascular function: a systematic review of randomised controlled trials of flavonoid-rich food products. , 2012, Molecular nutrition & food research.

[22]  R. Sinha,et al.  Association of coffee drinking with total and cause-specific mortality. , 2012, The New England journal of medicine.

[23]  Todd B. Parrish,et al.  Caffeine's effects on cerebrovascular reactivity and coupling between cerebral blood flow and oxygen metabolism , 2009, NeuroImage.

[24]  R. Draijer,et al.  Tea Consumption Enhances Endothelial-Dependent Vasodilation; a Meta-Analysis , 2011, PloS one.

[25]  Satoru Hayasaka,et al.  The effect of daily caffeine use on cerebral blood flow: How much caffeine can we tolerate? , 2009, Human brain mapping.

[26]  O. Witte,et al.  Effects of physiological aging and cerebrovascular risk factors on the hemodynamic response to brain activation: A functional transcranial doppler study , 2006, Clinical Neurophysiology.

[27]  Xavier Golay,et al.  Determining the longitudinal relaxation time (T1) of blood at 3.0 Tesla , 2004, Magnetic resonance in medicine.

[28]  J. Hogg Magnetic resonance imaging. , 1994, Journal of the Royal Naval Medical Service.

[29]  J. Mugler,et al.  Three‐dimensional magnetization‐prepared rapid gradient‐echo imaging (3D MP RAGE) , 1990, Magnetic resonance in medicine.

[30]  David Elashoff,et al.  Green and black tea consumption and risk of stroke: a meta-analysis. , 2009, Stroke.

[31]  Todd B. Parrish,et al.  Caffeine dose effect on activation-induced BOLD and CBF responses , 2009, NeuroImage.

[32]  D. Gusnard,et al.  Neurobiology of Disease Quantification of Indirect Pathway Inhibition by the Adenosine A 2 a Antagonist SYN 115 in Parkinson Disease , 2015 .

[33]  P. Svenningsson,et al.  Distribution, biochemistry and function of striatal adenosine A2A receptors , 1999, Progress in Neurobiology.

[34]  M. Lean,et al.  Espresso coffees, caffeine and chlorogenic acid intake: potential health implications. , 2012, Food & function.

[35]  I Biaggioni,et al.  Caffeine and theophylline as adenosine receptor antagonists in humans. , 1991, The Journal of pharmacology and experimental therapeutics.

[36]  Ihab Hajjar,et al.  Hypertension and Cerebral Vasoreactivity: A Continuous Arterial Spin Labeling Magnetic Resonance Imaging Study , 2010, Hypertension.

[37]  LenoreArab,et al.  Green and Black Tea Consumption and Risk of Stroke , 2009 .

[38]  G. Baumann,et al.  Green and black tea are equally potent stimuli of NO production and vasodilation: new insights into tea ingredients involved , 2009, Basic Research in Cardiology.

[39]  Yi Zeng,et al.  Tea drinking and cognitive function in oldest-old Chinese , 2012, The journal of nutrition, health & aging.

[40]  K. Welch Primer on cerebrovascular diseases , 1997 .

[41]  Yuichi Kimura,et al.  Imaging of adenosine A1 receptors in the human brain by positron emission tomography with [11C]MPDX , 2003, Annals of nuclear medicine.

[42]  R. Draijer,et al.  Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. , 2013, International journal of cardiology.

[43]  J. Miners,et al.  Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man. , 1986, British journal of clinical pharmacology.

[44]  M. Blinkenberg,et al.  Regional Differences in the CBF and BOLD Responses to Hypercapnia: A Combined PET and fMRI Study , 2000, NeuroImage.

[45]  G. Desideri,et al.  Blood pressure and cardiovascular risk: what about cocoa and chocolate? , 2010, Archives of biochemistry and biophysics.

[46]  Sandra N. Mohr,et al.  Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[47]  E. Williams Experimental Designs Balanced for the Estimation of Residual Effects of Treatments , 1949 .